Targeting the tumor microenvironment

Area of Science:

• Oncology
• Cancer Biology
• Drug Discovery

Background:

• Cancer remains a significant challenge despite advances in treatment.
• The tumor microenvironment, comprising stromal cells and signaling pathways, plays a critical role in cancer progression.
• Targeting tumor epithelial cells alone is insufficient for effective cancer therapy.

Purpose of the Study:

• To explore the intricate interactions between tumor epithelial cells and the surrounding stroma.
• To identify and review "druggable" targets and processes within the tumor microenvironment.
• To discuss therapeutic approaches aimed at disrupting these tumor-stroma interactions.

Main Methods:

• Review of current scientific literature on tumor microenvironment.
• Analysis of emerging therapeutic targets and drug development pipelines.
• Discussion of approved and investigational agents targeting microenvironmental components.

Main Results:

• Established synergy between tumor epithelium and stroma necessitates a broader therapeutic approach.
• Several key components and processes within the tumor microenvironment are identified as potential drug targets.
• Existing drugs (e.g., targeting VEGF, aromatase) demonstrate the viability of targeting the microenvironment.

Conclusions:

• Disrupting the dialogue between tumor cells and their microenvironment offers promising therapeutic avenues.
• Further research into tumor microenvironment interactions will yield novel strategies for cancer treatment.
• Targeting the tumor microenvironment represents a critical frontier in developing more effective cancer therapies.